Tafamidis 11014-0390
Product NDC
11014-0390- Manufacturer
- Catalent Pharma Solutions, Llc
- Dosage Form
- Capsule
- Product Type
- Drug For Further Processing
- Marketing Start
- April 3, 2019
- Listing Expires
- December 31, 2027
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tafamidis | 61 mg/1 |
Packaging Options(1)
1 BAG in 1 CARTON (11014-0390-2) / 3000 CAPSULE in 1 BAG